Alzheimer disease and biomarkers
Evaluating blood- and CSF-based biomarkers and understanding when biomarker results agree, or disagree, with established measures of Alzheimer disease pathology.
Research
Questions that matter at the bedside.
Rapidly progressive dementia
Improving recognition of rapidly progressive neurodegenerative syndromes and identifying clinical, imaging, and laboratory features that sharpen the differential diagnosis.
Prion disease
Studying diagnostic mimics and the real-world performance of tests used to distinguish prion disease from other causes of cognitive decline.